Today: 30 April 2026
Tesla stock rises in premarket as Musk flags “agonizingly slow” Cybercab, Optimus ramp and Lemonade bets on FSD

Tesla stock rises in premarket as Musk flags “agonizingly slow” Cybercab, Optimus ramp and Lemonade bets on FSD

NEW YORK, Jan 22, 2026, 09:21 (EST) — Premarket

  • Tesla shares climbed roughly 1.2% in premarket trading, building on Wednesday’s bounce.
  • Musk cautioned that early production of the Cybercab robotaxi and Optimus will be “agonizingly slow” initially, before picking up pace.
  • Insurer Lemonade announced it plans to lower rates for Tesla drivers using Full Self-Driving. Tesla, meanwhile, dismissed rumors about major layoffs at its Berlin-area factory.

Tesla shares climbed about 1.2% to $436.78 in premarket trading Thursday, following a 2.9% gain on Wednesday that closed at $431.44.

The stock is now a test of how quickly Tesla can deliver on its ambitious self-driving and robotics goals with concrete results. Next week’s earnings report and call will be right at the heart of that debate.

Elon Musk warned that initial production of Tesla’s Cybercab robotaxi and the Optimus humanoid robot will crawl before picking up speed, citing the complexity of new parts and manufacturing steps. He said the early output would be “agonizingly slow,” but predicted it would “eventually end up being insanely fast.” Reuters described the Cybercab as a two-seater without manual controls like a steering wheel or pedals. Reuters

Tesla announced it built 434,358 vehicles and delivered 418,227 in Q4, hitting a record 14.2 gigawatt-hours in energy storage deployments. The automaker plans to release its fourth-quarter earnings after the market closes on Jan. 28, followed by a live Q&A webcast at 5:30 p.m. Eastern.

Lemonade announced a 50% rate cut for Tesla owners when their cars are driven using the automaker’s Full Self-Driving (FSD) software. The insurer will rely on Tesla’s telemetry data to track FSD miles separately from human-driven ones under its pay-per-mile plans. Co-founder Shai Wininger told Reuters the company monitors “every minute, every second” a Tesla is on the road. Their data indicates FSD roughly halves the risk for the average driver, though he emphasized the technology “are not fully autonomous yet” and still needs a driver ready to take control. The offer will roll out in Arizona on Jan. 26, followed by Oregon in February. Reuters

For traders, the Lemonade shift stands out as an unusual external cue in a battle mostly shaped by Tesla disclosures and Musk’s tweets. It also brings insurance economics into the autonomy conversation, just as regulators ramp up demands for clarity on safety claims and real-world results.

Tesla has denied claims of major layoffs at its Berlin-area factory in Gruenheide, its only European production site. The company said there was “no significant reduction” in permanent staff compared with 2024, nor plans to cut headcount. This contradicts a Handelsblatt report that said the workforce had dropped by about 1,700 employees, or 14%, since 2024. Reuters

Berlin’s back-and-forth puts pressure on a familiar Tesla weakness: output and staffing come under the microscope as the company juggles tight execution margins while funding its next big project.

Yet moving from prototypes to mass production often shifts timelines. If Cybercab and Optimus scale up slowly, the stock will rely more heavily on the main car segment. New regulatory moves targeting driver-assistance features could also unsettle investors.

Investors have two key dates ahead: Lemonade’s rollout on Jan. 26 and Tesla’s earnings on Jan. 28. At the Tesla call, expect Elon Musk to field tough questions about Cybercab production schedules, Optimus milestones, and how quickly Full Self-Driving is advancing.

Stock Market Today

  • Extendicare (TSX:EXE) Valuation Review Amid Strong Share Price Surge
    April 30, 2026, 11:42 AM EDT. Extendicare (TSX:EXE) shares surged 43.22% year-to-date, with a current price of CA$30.19, drawing investor attention in senior care. The stock trades at a price-to-earnings (P/E) ratio of 29.5x, above the North American healthcare average of 24.5x, implying a premium for its earnings. However, it remains far below the peer average P/E of 79.2x, indicating relative restraint within its group. The company posted CA$96.66 million net income on CA$1.66 billion revenue, with a 5.8% net margin and 25.9% return on equity. A discounted cash flow (DCF) model suggests a fair value closer to CA$24.20, signaling the market may be pricing in future growth and stronger cash flows. Investors should weigh the valuation premium against sector risks and execution outlook before deciding.

Latest article

Social Security’s $4 Million Question: Can the S&P 500 Beat a 2033 Benefits Cliff?

Social Security’s $4 Million Question: Can the S&P 500 Beat a 2033 Benefits Cliff?

30 April 2026
A retiree’s claim that Social Security payroll taxes could have grown to $4 million in the S&P 500 has renewed debate over the system’s structure. The Social Security Administration projects its main trust fund will be depleted by 2033, with incoming revenue covering 77% of benefits. The fund invests only in government securities, not stocks. The payroll tax rate is set at 12.4% of earnings up to $184,500 in 2026.
Everspin Technologies Stock Surges After $40 Million Defense MRAM Deal Puts Growth Back in View

Everspin Technologies Stock Surges After $40 Million Defense MRAM Deal Puts Growth Back in View

30 April 2026
FatPipe shares jumped 18% to $2.92 Thursday after the company announced expanded access to its SD-WAN and cybersecurity products through public-sector procurement channels. The move follows a VeloCloud replacement program targeting customers of Arista Networks’ SD-WAN business. Trading volume reached 42.2 million shares. Investors remain cautious over execution and customer concentration risks.
Why Huachen AI Parking (HCAI) Stock Is Surging: Tiny Float, Reverse Split and Nasdaq Risk

Why Huachen AI Parking (HCAI) Stock Is Surging: Tiny Float, Reverse Split and Nasdaq Risk

30 April 2026
Huachen AI Parking shares surged as much as 135% in heavy Nasdaq trading Thursday, triggering four volatility halts. No new company filings or press releases explained the spike. The rally follows a 1-for-30 reverse stock split effective April 13, which sharply reduced the share count. Trading volume reached 34 million shares, far above the average of 727,390.
Cabaletta Bio stock jumps 11% premarket after insider buying cluster hits the tape
Previous Story

Cabaletta Bio stock jumps 11% premarket after insider buying cluster hits the tape

Moderna stock jumps again as Merck cancer vaccine data keeps MRNA rally running
Next Story

Moderna stock jumps again as Merck cancer vaccine data keeps MRNA rally running

Go toTop